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Abstract
Embryonic stem (ES) cells derived from the inner cell mass (ICM) of blastocysts are characterised by their ability to self-renew
and their potential to differentiate into many different cell types. Recent studies have shown that zinc finger proteins are
crucial for maintaining pluripotent ES cells. Mouse zinc finger protein 322a (Zfp322a) is expressed in the ICM of early mouse
embryos. However, little is known regarding the role of Zfp322a in the pluripotency maintenance of mouse ES cells. Here,
we report that Zfp322a is required for mES cell identity since depletion of Zfp322a directs mES cells towards differentiation.
Chromatin immunoprecipitation (ChIP) and dual-luciferase reporter assays revealed that Zfp322a binds to Pou5f1 and Nanog
promoters and regulates their transcription. These data along with the results obtained from our ChIP-seq experiment
showed that Zfp322a is an essential component of mES cell transcription regulatory network. Targets which are directly
regulated by Zfp322a were identified by correlating the gene expression profile of Zfp322a RNAi-treated mES cells with the
ChIP-seq results. These experiments revealed that Zfp322a inhibits mES cell differentiation by suppressing MAPK pathway.
Additionally, Zfp322a is found to be a novel reprogramming factor that can replace Sox2 in the classical Yamanaka’s factors
(OSKM). It can be even used in combination with Yamanaka’s factors and that addition leads to a higher reprogramming
efficiency and to acceleration of the onset of the reprogramming process. Together, our results demonstrate that Zfp322a is
a novel essential component of the transcription factor network which maintains the identity of mouse ES cells.
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Introduction
Embryonic stem (ES) cells, which are derived from the inner cell
mass (ICM) of mammalian blastocysts, are characterised by their
ability to self-renew and by their potential to differentiate into
many different cell types [1,2]. ES cells provide a prime platform
for biomedical research since the investigation of factors and
pathways that control pluripotency and differentiation provides us
with valuable data that will aid in the advancement of regenerative
[3]. The discovery that differentiated cells can be reprogrammed
into induced pluripotent stem cells (iPSCs) gave great promises for
the progress of regenerative medicine and gene therapy [4–7].
It has been discovered that transcription factors play crucial
roles in controlling ES cell identity. Genome-wide analyses revealed
that in mammalian ES cells, Oct4, Nanog and Sox2 form the core
transcriptional circuitry that activate genes involved in self-renewal
andpluripotencyand repressgenesthatpromotedifferentiationinto
different lineages [8,9]. The importance of this transcription
network was subsequently highlighted by the finding that the
expression of just four transcription factors, Oct4, Sox2, c-Myc and
Klf4 (OSKM) was sufficient to transform mouse embryonic
fibroblasts (MEFs) back to pluripotent stem cells, and the expression
of OCT4, SOX2, NANOG and LIN28 was sufficient for in human
somatic cell reprogramming [6,7]. Along with these core factors,
there are many other transcription factors which closely interact
withthese factors (i.e. form the gene regulatory network). Hence it is
important to unravel the functions of all components in order to
fully understand how this regulatory network functions to regulate
various target genes. Therefore, it is of great value to expand our
knowledge of this transcription regulatory network.
Kru ¨eppel associated box (KRAB) C2H2 zinc finger family can
interact directly with specific cis-regulatory DNA elements to
regulate genes’ activities [10]. Several studies have revealed that
proteins from this family, such as ZSCAN4, Zfp296, Zfp206, and
Zfp42, are key components of the ES transcriptional network and
are crucial for maintaining pluripotent ES cells [11–15]. Mouse
zinc finger protein 322a (Zfp322a) is another evolutionarily
conserved protein that belongs to this family [16]. We proposed
that Zfp322a acts as a transcription factor in mouse ES cells for
two main reasons: First, ChIP-seq data from a previous study
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Myc bind to the genomic region of Zfp322a [17]. Second, Zfp322a
is expressed at a higher level in mES cells compared to trophoblast
cells [18]. Additionally, single cell RNA-seq results have demon-
strated Zfp322a expression in both mouse ICM and ES cells [19].
These results suggested a potential role for Zfp322a in controlling
the identity of mES cells. However, there has been little
information regarding the function of Zfp322a.
In this study, we demonstrated that Zfp322a is required for the
maintenance of mouse ES cell identity. Depletion of Zfp322a
impairs mES cell self-renewal and induces them to differentiate.
We found that Zfp322a positively regulates Pou5f1 and Nanog
expression, and possibly represses MAPK/ERK pathway, thus
preventing mES cells from differentiation. Further genome wide
studies also identified the targets of Zfp322a which are involved in
a variety of biological processes, including DNA transcription and
translation, chromosome organization, development, DNA repair,
cell cycle and apoptosis. Through iPSC formation assays we
discovered that Zfp322a can be used as a novel reprogramming
factor and the reprogramming efficiency was enhanced by the
addition of Zfp322a to OKSM. Together, these results established
Zfp322a as a novel pluripotency factor that can enhance
reprogramming process.
Results
1. Zfp322a is required for the maintenance of mES cell
self-renewal and pluripotency
Chen et al. demonstrated that Oct4, Zfx, E2F1, Klf4 and Myc
bound to an 800 bp-region in the third intron of Zfp332a [17]
(Figure S1A). Our ChIP results confirmed the interaction between
Oct4 and Zfp322a intron (Figure S1B). This suggested that
Zfp322a is a direct target of regulation by these transcription
factors. In previous studies Zfp322a was discovered to be
expressed at a higher level in ICM compared to trophectoderm
[18]. We further examined the expression of Zfp322a in mES cells
by immunostaining assay (Figure S2A), using the antibody specific
for Zfp322a protein (Figure S2B). We found that Zfp322a was
mainly localized in the nucleus of mES cells, which indicates that
as a zinc finger protein, Zfp322a may function as a transcription
factor in mES cells.
To determine thechangeintheexpression ofZfp322a uponmES
cell differentiation, mouse ES cells were induced to differentiate by
culturing in LIF (leukemia inhibitory factor) withdrawal medium.
Zfp322a mRNA level was reduced during the differentiation
process, dropping to 20% at 7 days after LIF removal (Figure 1A).
Similarly, Zfp322a protein also decreased upon mES cell differen-
tiation (Figure 1B). The expression of Zfp322a in undifferentiated
mES cells and its repression upon ES cell differentiation further
suggested a possible involvement of Zfp322a in pluripotency
maintenance in mouse ES cells.
In order to investigate the role of Zfp322a in mouse ES cell
pluripotency, we examined the effect of Zfp322a depletion in mES
cells by RNAi. E14 mES cells were transfected with two
independent Zfp322a shRNAs targeting different regions of
Zfp322a gene. Both shRNAs were effective in depleting the level
of Zfp322a mRNA to 30% of the control (Figure 1D). Upon knock-
down of Zfp322a, mES cells lost their characteristics, including the
round colony-like morphology and alkaline phosphatise (AP)
activity. Instead, RNAi-treated cells exhibited flattened, differen-
tiated cell morphology (Figure 1C). These results indicated that
Zfp322a depletion caused mES cell differentiation and impaired
self-renewal of mES cells.
2. Depletion of Zfp322a activates developmental genes
while repressing pluripotency related genes
We further examined the alteration in gene expression induced
by Zfp322a depletion. The mRNA levels of pluripotency genes
Pou5f1, Nanog, Sox2 and Zfp42 were significantly reduced in RNAi-
treated E14 cells (Figure 1D). Consistently, protein levels of these
pluripotency factors were also reduced upon Zfp322a depletion
(Figure 1E, 1F). In addition, immunofluorescence (IF) of Oct4 and
Nanog were performed to examine their expression at cellular
level. The fluorescence intensities of Zfp322a knocked-down cells
and control cells were measured with flow cytometry. Upon
Zfp322a RNAi, there was a significant reduction of the fluores-
cence intensities observed both in anti-Oct4 antibody and anti-
Nanog antibody stained cells (Figure 1G). Further we examined
the population mean value of fluorescence intensities. We found
that Zfp322a depletion supressed Oct4 and Nanog IF mean
intensities by 50%, 40% respectively as compared to control
(Figure 1H). Similar results were obtained in another mES cell line
HM1 (Figure S5A). Since Oct4 and Nanog are essential for
maintenance of pluripotency, these results are consistent with the
observation that Zfp322a RNAi induces differentiation of mES
cells. The differentiation of mES cells was further supported by the
dramatic increase in various lineage markers after Zfp322a
depletion (Figure 1I). Upon knock-down of Zfp322a in mES cells,
we observed an up-regulation of endodermal markers: Gata6 (4
fold), Foxa2 (8 fold) and Sox17 (3 fold), which indicated that
Zfp322a could maintain mES cell pluripotency by repressing
endodermal specification. Trophectoderm maker Cdx2 displayed a
16 fold increase while mesoderm markers, Fgf5, Hand1 and Nkx2.5
increased by 7, 8 and 10 fold respectively (Figure 1I). Thus
consistent with the AP staining results, this suggested that Zfp322a
is required to suppress lineage specific gene expressions to
maintain mES cells in their undifferentiated state.
To further understand how Zfp322a depletion led to mES cell
differentiation, we used gene expression microarrays to investigate
the global gene expression profile changes induced by Zfp322a
depletion (Figure 2A). qPCR experiments were performed to
validate the results of the microarray analysis (Figure S3). As an
internal control, we examined the level of Zfp322a by the
microarray, and consistent with qPCR results (Figure 1D), we
found an approximately 3-fold reduction in the mRNA level of
Author Summary
Embryonic stem (ES) cellsarefeatured by theirability toself-
renew and by their potential to differentiate into many
different cell types. Recent studies have revealed that the
unique properties of mouse ES cells are governed by a
specific transcription regulatory network, including master
regulators Oct4/Sox2/Nanog and other pluripotency fac-
tors. Theimportanceof thesefactorswashighlighted bythe
subsequent finding that combination of several transcrip-
tion factors can reprogram differentiated fibroblasts back to
pluripotent stem cells. Here, we report that Zfp322a is a
novel factor which is required for mES cell identity. We
revealed that Zfp322a can regulate the key pluripotency
genes Pou5f1 and Nanog and functions as a repressor of
MAPK/ERK pathway in mES cells, therefore preventing mES
cell differentiation. Furthermore, we discovered that
Zfp332a can promote the generation of induced pluripo-
tent stem cells (iPSCs) from mouse embryonic fibroblasts
(MEFs). Our results reveal that Zfp322a is a novel essential
transcription factor which not only regulates ES cell
pluripotency but also enhances iPSC formation.
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(increased by .1.5 fold) and 904 genes were down-regulated
(reduced by .1.5 fold) (Figure 2A). Importantly, the microarray
data analysis revealed that many known pluripotency genes were
down-regulated (Figure 2A). This indicated that Zfp322a is a high-
level regulator in the mES cell gene regulatory network, which
does not only regulate a subset of genes required for pluripotency,
but is an essential component of the core network required for the
maintenance of mES cell identity.
To determine whether Zfp322a regulated specific types of gene,
we conducted gene ontology (GO) analysis of up-regulated and
down-regulated genes. The enriched terms were summarized in
Figures 2A (Full list of the enriched terms can be found in Table
S1.). For the up-regulated genes, many terms related to
development were enriched. This is consistent with the role of
Zfp322a as a repressor of differentiation. Furthermore, Zfp322a
depletion activated cell apoptosis related genes, also explained the
increased apoptosis in Zfp322a RNAi-treated cells. Interestingly,
many terms were related to chromosome remodelling, suggesting
that Zfp322a may contribute to maintenance of the unique mES
chromatin structure. Notably, several signaling pathways impli-
cated in pluripotency such as MAPK pathway, Wnt signaling
pathway, Ras signal cascade were also affected after Zfp322a
depletion (Table S1, S2, Figure 2A, 2B). Importantly, Zfp322a
depletion caused an up-regulation of phosphorylated ERK
(p-ERK) level while the total levels of ERK (t-ERK) expression
was not affected (Figure 2C). This substantiated that Zfp322a
indeed is implicated in the repression of MAPK/ERK cascade
without changing ERK expression in mES cells (Figure 2C).
It has been shown that inhibition of MAPK/ERK pathway is
important for mES ground state pluripotency [20,21]. Activation
of Ras-MAPK pathway promotes trophectoderm induction and is
specifically suppressed by Oct4 in undifferentiated mES cells [22].
ERK pathway has been found to promote the onset of mES cell
differentiation and it is involved in multiple developmental
processes [23]. Therefore, Zfp322a may maintain mES cell in
undifferentiated state via repression of the MAPK/ERK cascade.
To further investigate the role of Zfp322a in MAPK pathway,
we next examined whether inhibition of the MAPK pathway could
rescue the effects caused by Zfp322a depletion. Zfp322a depleted
mES cells were subjected to 50 nM, 250 nM and 1 uM of ERK
inhibitors (PD0325901, Sigma). We found that the addition of
ERK inhibitors could not rescue the down-regulated Pou5f1, Sox2
and Zfp42 upon Zfp322a depletion, and the ERK inhibitor treated
cells exhibited differentiated morphology same as DMSO treated
control cells (Figure S3B). However, with the addition of ERK
inhibitors, levels of Nanog, Sox2 and Rex1 were higher than that of
Zfp322a depleted cells without ERK inhibitor and the endoderm and
ectoderm lineage markers were lower (Figure S3B, S3C). This is
consistent with previous findings in which the blocking of ERK
pathway induces elevated expression of Nanog in ES cells [24,25].
However, ERK inhibitor did not rescuestem cell differentiationcaused
by Zfp322a knocked-down cells (Figure S3B, S3C). Interestingly,
addition of ERK inhibitors seemed to facilitate Zfp322a knocked-down
cells to differentiate into mesoderm lineage, other than endoderm or
ectoderm lineages cells (Figure S3B, S3C). This is in consistent with
previous finding that Erk2-null mES cells tend to differentiate to
m e s o d e r ml i n e a g em o r ee f f i c i e n t l yt h a nw i l dt y p em E Sc e l l s[ 2 5 ] .
Taken together, it appears that Zfp322a depletion leads to
activation of MAPK/ERK pathway, which could drive mES cells
towards differentiation. However, the inhibition of MAPK/ERK
pathway could not rescue the differentiation phenotype caused by
Zfp322a loss.
3. Transcriptional regulation of Pou5f1 and Nanog by
Zfp322a
Oct4 and Nanog are master regulators of mES pluripotency
[26,27]. Many pluripotency factors were found to bind to
promoters of Pou5f1 and Nanog to regulate their transcriptions
[17]. Since Nanog and Pou5f1 were down-regulated upon Zfp322a
depletion, we speculated that Zfp322a may bind to Pou5f1 and
Nanog promoters to regulate their transcription. To test whether
Zfp322a binds to cis-regulatory elements of Pou5f1 and Nanog,
ChIP experiments were performed using an anti-Zfp322a
antibody to pull-down wild type mES cell chromatin. Real-time
PCR was used to determine whether Zfp322a preferentially bound
to known enhancer elements upstream of Pou5f1 and Nanog
promoters. We found a clear peak in the Pou5f1 distal enhancer,
which is also known as CR4 (conserved region 4), showing a 28
fold enrichment (Figure 3A, S5B). CR4 is the main enhancer that
drives Pou5f1 expression in mouse ES cells and early embryos, and
it is the site bound by many transcription factors, including Nanog,
Sox2 and Oct4 itself [8,28,29]. Similarly, Zfp322a was also shown
to bind to the Nanog proximal promoter. Strong enrichment for
amplicon 4 was found in the multiple transcription factor binding
locus of Nanog promoter (MTL) (Figure 3B, S5C) [13]. These
results showed that Zfp322a could directly bind to Pou5f1 distal
enhancer and Nanog proximal promoter in mES cells and may
cooperate with other transcription factors in the regulation of
Pou5f1 and Nanog transcription.
To determine whether Zfp322a regulates the transcription of
Pou5f1 and Nanog, dual-luciferase assays were performed using two
constructs Pou5f1 CR4-pSV40-Luc and pNanog pp-Luc. Interest-
ingly, upon knock-down of Zfp322a, the luciferase activities were
strikingly reduced to 20% and 30% respectively in constructs
carrying the CR4 or the Nanog proximal promoter (Figure 3C, 3E,
S5D). To determine whether this reduction was led by Zfp322a loss
directly, Pou5f1 CR1 was chosen as negative control. ChIP
experiments showed a relatively lower enrichment fold at this
region as compared to CR4. As expected, in the experiment with
Figure 1. Zfp322a is required for ES pluripotency. (A) Zfp322a mRNA level was decreased in mES cells cultured in LIF withdrawal ESC medium.
The level of the Zfp322a and Pou5f1 mRNA were compared to control cells cultured in normal ESC medium and normalized against b-actin.( B)
Zfp322A protein level showed a reduction as mES cells differentiated. b-actin served as loading control. (C) Zfp322a RNAi caused ES cell
differentiation. AP staining was conducted on the fourth day of selection after the cells were transfected with Zfp322a shRNAs. Zfp322a RNAi cells
displayed a lighter colour compared to the dark red colour of mock RNAi cells. (D) Pluripotency genes were down-regulated upon Zfp322a RNAi. ES
cells transfected with empty pSUPER.puro vector were used as a control and gene expression levels were normalized against b-actin.( E) Zfp322a RNAi
resulted in decreased Oct4, Nanog, Sox2 and Rex1 protein. b-actin served as loading control. (F) Quantification of the protein level changes. Protein
levels of Zfp322a knocked-down cells were normalized against b-actin and compared to control RNAi cells using software ImageJ. (G) Representative
flow cytometry results showed that fluorescence intensities of Oct4 and Nanog were repressed in Zfp322a depleted cells as compared to control cells.
(H) Zfp322a depletion led to reductions of Oct4 and Nanog expression at cellular levels. The mean of fluorescence intensity was calculated using
software flow software 2.5.0. Relative fluorescent intensities of Zfp322a RNAi cells were normalized against control knocked-down cells. Standard
deviations were derived from three independent experiments. (I) Zfp322a RNAi caused up-regulation of lineage specific markers for endoderm,
mesoderm and trophectoderm. Specific primers were used to check the respective gene expression levels by real-time PCR.
doi:10.1371/journal.pgen.1004038.g001
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PLOS Genetics | www.plosgenetics.org 4 February 2014 | Volume 10 | Issue 2 | e1004038Figure 2. Changes of global gene expression upon Zfp322a knock-down in ES cells. (A) Microarray heat map generated from relative gene
expression levels. Zfp322a was knocked down in E14 cells and the cells were selected for 96 hours before whole genome cDNA microarray
hybridization was performed. Duplicates were performed to ensure reproducibility of results. Relative highly expressed genes were shown in red and
low expressed genes in green. 1574 genes showed an increased expression level of more than 1.5 fold after Zfp322a RNAi. Gene onthology analysis
was performed relating to ‘‘biological process’’. The enriched terms were classified into several function groups and listed in the figure. Many terms
related to developmental processes were enriched. 904 genes expression level showed more than 1.5 fold reduction. Examples of down-regulated
pluripotency-related genes upon Zfp322a knock-down in ES cells. Genes were selected according to their known functions in pluripotency or ES cells.
Each selected gene was taken as individual tiles from the thumbnail-dendogram duplicates. (B) List of up-regulated MAPK pathway related genes
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PLOS Genetics | www.plosgenetics.org 5 February 2014 | Volume 10 | Issue 2 | e1004038upon Zfp322a RNAi. Genes were selected as they fell into the cluster ‘‘MAPK signaling pathway’’ according to gene ontology analysis for enriched
KEGG pathways. Each selected gene was taken as individual tiles from the thumbnail-dendogram duplicates. (C) Phosphorylated ERK (p-ERK) level
was elevated in Zfp322a depleted cells as compared to control cells, while the total ERK (t-ERK) level was not affected. b-actin served as a control for
normalization.
doi:10.1371/journal.pgen.1004038.g002
Figure 3. Zfp322a positively regulates Oct4 and Nanog transcription. (A) Zfp322a binds to Oct4 distal enhancer regions. Zfp322a ChIP DNA
was analyzed by real-time PCR. Locations of primers used in qPCR were mapped to the Pou5f1 genomic region. (B) Zfp322a binds to Nanog proximal
promoter, with a highest enrichment fold at TSS starting site. Locations of primers were pictured on mouse Nanog genomic region. Relative luciferase
activities were down-regulated upon Zfp322a RNAi using Pou5f1 CR4-pSV40-Luc construct (C) and pNanog PP-Luc construct (E), but not Pou5f1 CR1-
pSV40-Luc construct (D). Schematic structures of the constructs were presented. Empty pSUPER.puro vector were transfected in ES cells as a control
RNAi. Renilla luciferase vector were transfected simultaneously and relative luciferase activities were normalized against Renilla luciferase activity.
doi:10.1371/journal.pgen.1004038.g003
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reduced by 15% upon Zfp322a depletion, much less than 80%
reduction observed in the CR4 experiment (Figure 3D). These
strongly suggested that Zfp322a directly regulated Pou5f1 and
Nanog through binding to these cis-regulatory elements. Interest-
ingly, it was also observed that compared to single knock-down of
Pou5f1, double knock-down of Pou5f1 and Zfp322a further
suppressed enhancer activities, (Figure S4A, S4B). Given that
Oct4 also binds to CR4 and Nanog MTL to regulate the
transcriptions [8], we hypothesized that Zfp322a may cooperate
with Oct4 to regulate gene transcriptions.
4. Genome-wide mapping of Zfp322a binding sites in
mES cells
To gain more insights into the downstream pathways through
which Zfp322a functions, we identified genome-wide binding sites
of Zfp322a in mouse ES cells. Following chromatin immunopre-
cipitation using anti-Zfp322a antibody to enrich the DNA
fragments bound by Zfp322a, we used high-throughput sequenc-
ing (ChIP-seq) to analyze the ChIP-enriched DNA. Genomic
regions defined by multiple overlapping DNA fragments derived
from the ChIP enrichments were considered as putative binding
sites. To confirm the validity of these putative binding sites,
genomic loci with peaks of various fold changes were arbitrarily
selected and tested by qPCR. The final threshold value was
determined based on enrichment of 2 fold in qPCR validation
(Figure S6), which corresponded to 9-fold or higher enrichment in
the ChIP-seq experiment. This gave a total of 4382 putative
binding sites of Zfp322a that were associated with 4056 genes
(Table S3).
The location of the binding site within the gene was mapped as
well (Figure 4A). Notably, after putative Zfp322a binding sites
were mapped to nearest genes, 62% fall within the TSS of the
nearest to gene, showing an obvious preference for TSSs
(Figure 4B). 19% of the loci were within gene intronic regions,
followed by 59 UTR, distant promoter (.3 kb from TSS) and
promoter (,3 kb from TSS) which occupied 6% each (Figure 4B).
Thus, we proposed that Zfp322a is primarily associated with gene
promoters.
Among highly enriched binding sites-associated genes, there
were many known key components of ES transcription regulatory
network, such as Ino80d, Zfp206, Zfx, Nrf1, Smarce1, implying that
Zfp322a could directly regulate transcription of these pluripotency
genes (Table S3). To further examine whether Zfp322a targets
have preferentially any particular biological functions in mES cells,
genes associated with the putative binding sites were subjected to
Gene Ontology to search for enriched biological process terms.
Large numbers of terms were found to be related to cellular
metabolic and biosynthetic processes. Other enriched terms were
classified into function groups and summarised in Table S4.
Similar to GO analysis of our microarray data, Zfp322a targets
were involved in regulation of gene transcription and translation,
especially transcription from RNA polymerase II promoter.
Notably, Zfp322a binding sites were found near genes encoding
core components of RNA polymerase, such as Polr2a, Polr2j, Polr3e.
We also found that the targets of Zfp322a were related to
developmental processes, implying that Zfp322a may participate
in mouse embryo development through regulation of these genes.
In addition, many terms surrounding the functions ‘‘DNA repair’’,
‘‘protein modifications’’, ‘‘cellular component localization’’, and
‘‘RNA processing’’, were enriched.
Besides Pou5f1 and Nanog, we sought to refine our prediction of
Zfp322a targets by combining ChIP-seq and microarray data in
pluripotent mES cells. We analysed the ChIP-seq in concert with
microarray dataset. Overlapping genes between these two sets of
data indicated that these genes could be directly regulated by
Zfp322a, either positively or negatively. We found that 401 of the
1574 up-regulated genes in the Zfp322a-RNAi microarray data
analysis were directly repressed by Zfp322a in mES cells, while
223 genes were activated directly (Figure 4C). Further GO analysis
of the directly repressed targets, showed that MAPK pathway
related genes was enriched (p value=0.006, Table S5). This
reaffirmed our hypothesis that Zfp322a represses MAPK signalling
pathway to maintain mES cell pluripotency.
5. Computational analysis of Zfp322a binding sites
Next, we aimed to identify the Zfp322a binding motif. Through
bioinformatic computation, we found three different motifs which
repeatedly occurred in Zfp322a binding sites; albeit at low
frequencies (Figure 4D). Motif 1 had the highest frequency,
presenting in 9% of all the binding sites. Motif 2 was a 12 bp-
polyA-sequence with a frequency of 5%. The third motif, which
was found in 4% of all binding sites, showed a high similarity to
the Oct4/Sox2 binding motif [17]. This suggested that Zfp322a,
Oct4 and Sox2 often bind to the same enhancer element, either
acting as a complex or interacting in other ways. Notably, the first
and the third element are present in the CR4 element of Pou5f1
and the proximal promoter of Nanog. It is expected that the actual
Zfp322a binding site was not identified as a consensus binding
motif, given that Zfp322a protein harbours 10 zinc fingers, while
only 3–5 zinc fingers were needed for specific DNA binding [30].
Therefore, different zinc fingers of Zfp322a possibly recognise
distinct sequences, leading to a wide variety of Zfp322a binding
motifs.
Given the possibility that Oct4/Sox2 binding sites tended to be
present near Zfp322a binding sites, we compared Zfp322a binding
sites with target sequences of other transcription factors mapped in
previous studies [17]. All the transcription factors were clustered
according to the similarity of the co-localization with other factors.
The results showed that Zfp322a was closer to the Myc cluster
(Figure 4E). But with a closer check of the results, Zfp322a actually
had a ubiquitous comparable correlation with all the 12
transcription factors, and did not show any significant preference
for either Myc or Oct4/Sox2 centred clusters. Indeed Zfp322a
showed a slightly higher co-localization frequency with Oct4
cluster target, from which it was inferred that Zfp322a may
facilitate or cooperate with Oct4 in mES cells.
Given the correlation between Zfp322a targets and Oct4
targets, similarities between Oct4/Sox2 and Zfp322a binding
motifs, together with our observation that both Zfp322a and Oct4
bound to the CR4 region of Pou5f1 distal promoter and Nanog
proximal promoter at the same regions, we sought to determine
whether Zfp322a could physically interact with Oct4. Co-IP
experiments were performed with either anti-Zfp322a antibody or
anti-Oct4 antibody. Western blots were then carried out with anti-
Oct4 antibody or anti-Zfp322a antibody. We observed an Oct4
band in Zfp322 IP lane and Zfp322a band in Oct4 IP lane,
indicating that Zfp322a physically interacts with Oct4 in mES cells
(Figure 4F). This confirmed our hypothesis that Zfp322a functions
as a partner of Oct4 in the regulation of gene transcription, though
previous studies did not list Zfp322a as an Oct4 partner [31,32].
6. Zfp322a can enhance OKSM reprogramming of MEFs
into iPSCs
Since Zfp322a is involved in mES cell self-renewal and
pluripotency regulation, it would be interesting to investigate
whether overexpression of Zfp322a can enhance OSKM repro-
gramming or act as a novel reprogramming factor to replace any
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PLOS Genetics | www.plosgenetics.org 7 February 2014 | Volume 10 | Issue 2 | e1004038Figure 4. Genomic-wide analysis of Zfp322a binding sites. (A) Schematic definitions of locations of the putative Zfp322a binding sites relative
to the nearest transcriptional unit. TSS referred to 21000 to +100 bp from 59-end of annotated RNA. (B) Genomic distributions of Zfp322a binding
loci. (C) Identification of genes that were predicted to be directly regulated by Zfp322a. The datasets from microarray analysis and ChIP-Seq targets
were calculated for overlapping genes. The results revealed 1574 tentative genes that likely were activated and 223 tentative genes repressed directly
by Zfp322a. (D) Predicted binding motifs for Zfp322a. Motifs were computationally determined based on the ChIP-Seq data. Three different motifs
were identified, namely motif 1, motif 2, motif 3, with frequencies of 9%, 5%, 4% respectively. (E) Zfp322a can be integrated within ES cell
transcription regulatory network. Shown was co-occurrence of transcription factors at the multiple binding loci. Colours in the heat map reflected the
co-localization frequency of each pair of transcription factors (the darker the color was, the more frequently colocalized). All the transcription factors
were clustered according to the colocalization frequency with other factors, which was calculated based on their co-occurrence at the same binding
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a Pou5f1-GFP reporter were used to identify putative iPSC
colonies [33]. It was observed that MEFs infected with OSKM
plus Zfp322a showed a more efficient and faster reprogramming
process than OSKM alone (Figure 5A). Addition of Zfp322a could
enhance the kinetics of OKSM reprogramming as GFP expressing
colonies were detected earlier than OKSM control. The number
of iPSCs, when counted as GFP
+ colonies formed by OKSM plus
Zfp322a was higher than OKSM throughout the whole repro-
gramming process. By day 14 of reprogramming process, the
number of GFP
+ colonies generated from OKSM plus Zfp322a
was 1.4 fold higher than control. Further examination of these
iPSC colonies by AP staining also showed more AP positive
colonies formed by OKSM plus Zfp322a as compared to OKSM
alone (Figure 5B).
Next, the pluripotency of the iPSCs generated by OKSM plus
Zfp322a were evaluated. The expression of GFP suggested that
Pou5f1 promoter was strongly reactivated in iPSCs generated from
OKSM plus Zfp322a. IF staining results confirmed that these
iPSCs expressed pluripotency markers Oct4, Nanog, Sox2 and
Rex1. ES cell marker SSEA-1 was also expressed in the iPSCs
generated from OKSM plus Zfp322a (Figure 5C). To further
characterize the pluripotency of these iPSCs, embryoid body (EB)
formation assays were performed to examine whether these
reprogrammed cells were able to differentiate into three germ
layers. iPSCs were cultured in suspension to form EBs and then
transferred to coated plate with EB differentiation media for 14
days before they were stained with lineage markers. We found that
EBs derived from those iPSCs were able to express endoderm
marker Gata4, mesoderm marker alpha smooth muscle actin
(SMA) and ectoderm marker Nestin (Figure 5D). Therefore, it was
demonstrated that iPSCs generated from OKSM plus Zfp322a
were pluripotent and closely resembled mES cells. Taken together,
we concluded that Zfp322a could induce OKSM reprogramming
of MEFs into iPSCs more efficiently and faster.
7. Zfp322a can replace Sox2 in the OKSM reprogramming
We then investigated whether Zfp322a can replace the core
reprogramming factors in addition to enhancement of reprogram-
ming efficiency. Given that c-Myc is dispensable for reprogram-
ming [34,35], we only investigated whether Zfp322a can replace
any of the OKS factors to generate iPSC colonies from MEFs.
Zfp322a was unable to replace Oct4 or Klf4, however, there were
GFP
+ colonies observed in the MEFs infected with Zfp322a plus
OKM (Figure 5E). This indicated that exogenous Zfp322a could
replace Sox2 in OKSM reprogramming, albeit at a lower
efficiency than OKSM. The first GFP
+ colony generated from
Zfp322a plus OKM was observed later as compared to OKSM
control. In addition, the expression of GFP was weaker and the
number of GFP
+ colonies was fewer (Figure 5E, 5F, Figure S7A).
Similar to iPSCs formed from OKSM plus Zfp322a, these iPSC
colonies were positive for AP staining (Figure 5F, Figure S7B).
Further examination of the pluripotency profile of these iPSCs
showed that these iPS colonies could be stained with anti-SSEA-1,
anti-Oct4, anti-Nanog, anti-Sox2 and anti-Rex1 antibodies, and
were able to express all three lineage markers when they were
induced to differentiate in the EB formation assays (Figure 5G,
5H). These suggested that Zfp322a could replace Sox2, but the
combination of OKM plus Zfp322a might have relatively slower
kinetics in generating iPSCs than OKSM.
Discussion
The unique properties of mES cells are governed by the master
regulators Oct4, Nanog and Sox2, along with a variety of
transcription factors (TFs) [17]. These transcription factors form a
complex network to regulate mES cell identity. So far, a lot of TFs
have been identified to be important for mES cell identity.
However, it is still important to identify novel transcription factors
since depletion of a single factor will alter mES cell pluripotency
[36,37]. Our research revealed for the first time that Zfp322a is a
transcription factor which is important in maintaining mES cells in
undifferentiated state.
Our results have demonstrated that depletion of Zfp322a
through RNAi induced differentiation of mES cells. The
differentiation of mES cells could be due to the suppression of
Pou5f1 and Nanog expression after Zfp322a was depleted. Zfp322a
was shown to actively regulate Pou5f1 transcription through
binding to the CR4 region, and activate Nanog transcription via
Nanog MTL, which are the co-binding sites of other pluripotency
factors. Our ChIP-seq and microarray analysis further revealed
the binding of Zfp322a to the locus of many other key pluripo-
tency genes that were down-regulated upon Zfp322a depletion. It
is interesting that Zfp322a can regulate Pou5f1 and Nanog
transcription, while Zfp322a itself may also be a target of Oct4
and other pluripotency genes (Figure S1). It appears that these
pluripotency factors can form a regulatory loop within the
transcriptional network controlling the pluripotency of mES cells.
Thus it can be inferred that Zfp322a is a regulator of mES cells by
targeting or possibly cooperating with other pluripotency factors.
Moreover, our gene ontology analysis of ChIP-seq and
microarray data strongly suggested that Zfp322a targets are
involved in embryonic development process and related pathways.
Zfp322a is implicated as a pluripotency factor because of its
relatively high expression in ICM and undifferentiated mouse ES
cells. Since the general reduction trend of Zfp322a expression
correlates with a commitment to differentiation and a transient up-
regulation of Zfp322a at third day of differentiation possibly
indicates a specific role of Zfp322a in regulating early lineage
commitments. We speculate that Zfp322a not only simply
maintains mES cell in their undifferentiated state but also has
certain roles in lineage specifications in embryo development.
However, these would warrant further studies.
Notably over-expression of Zfp322a in mES cells did not
significantly change cell morphology (Figure S8A). Interestingly,
Nanog level was activated via Nanog proximal promoter in
Zfp322a over-expressing mES cells, while Pou5f1 level showed
no significant change over control (Figure S8B, C). Nanog is a
well-known core regulator of ES cells, which can sustain ES cell
pluripotency in the absence of LIF [27,38]. The activation of Nanog
was also observed in a lot of other pluripotency factors, such as
Zfp296, Nr5a2, Zic3 etc. [12,39,40]. All of these factors are
required for maintaining ES cells in their undifferentiated state
and can induce Nanog expression when over-expressed in ES cells.
Moreover, our microarray data and ChIP-seq results showed that
Zfp322a can repress MAPK/ERK pathway. It is highly possible
that Zfp322a, when over-expressed, may serve as an ERK
loci. (F) Zfp322a can interact with Oct4. Cell lysate of wild type ES cells were immunoprecipitated using either anti-ZNF322A antibody or anti-Oct4
antibody. Western blot was subsequently carried out with anti-Oct4 antibody or anti-ZNF322a antibody. Control IP was performed using anti-IgG
antibody.
doi:10.1371/journal.pgen.1004038.g004
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mimicking high and homogeneous Nanog expression in ‘‘2i+LIF’’
ES culturing media containing ERK inhibitors [20,24,25].
Therefore we hypothesize that Zfp322a can activate Nanog
expression either directly or indirectly via MARK/ERK pathway
inhibition to maintain the ground pluripotency in mES cells.
In our results, we also discovered the interaction between Oct4
and Zfp322a and presence of a similar binding motif for Zfp322a
and Oct4/Sox2. This is in concert with the observed higher co-
occurrence frequency between Oct4 and Zfp322a binding loci
based on the ChIP-seq analysis. Indeed, when we compared the
gene expression profile changes after Zfp322a RNAi with Pou5f1
RNAi, a large number of high overlapping targets were identified
(Figure S9) [8]. Gene ontology analysis of these co-targeting genes
displayed a large number of terms related to cellular, organic,
embryonic development, cell proliferation and apoptosis, chro-
matin remodelling, DNA transcription etc. (Table S6). In addition,
many Oct4-interacting proteins were also affected in the
microarray data analysis (Table S7). These implied a close
correlation between Zfp322a and Oct4.
Furthermore, the observation of replacement of Zfp322a to
Sox2 in OKSM reprogramming verified Zfp322a facilitation of
Oct4 functions. Sox2 was discovered as a transcription factor that
binds next to Oct4 motif, thus acting synergistically to active gene
transcriptions [8,9]. But subsequent studies have indicated that
Sox2 functions redundantly in the activation of Oct-Sox element
[41]. It is then suspected that Zfp322a could have roles partially
redundant with Sox2 to interact with Oct4 and participate in
Oct4/Sox2 gene regulations. Besides, it is noteworthy that
Zfp322a knock-down also depleted expression of Sox2, which
suggested that Zfp322a is required for Sox2 activation (Figure 1D,
1E). Therefore, Zfp322a may play a similar function of Sox2 or
activate Sox2 expression to mediate its functions.
However, as a Kru ¨ppel-like zinc finger transcription factor,
Zfp322a may have more complex roles in mES cells since these
zinc finger transcription factors have evolved to fill roles in many
different biological processes [42]. Indeed, our further analysis of
genome-wide Zfp322a target sequence revealed that Zfp322a
displayed a non-preferential consensus sequence binding and
ubiquitously co-localized with other key pluripotency regulators.
Therefore, the ubiquitous association with other factors and
diverse implicated functions from microarray and ChIP-seq
analysis render Zfp322a functions more complicated. Given that
Zfp322a protein contains 10 zinc finger motifs, it might associate
with a wide variety of co-factors through different fingers, and
therefore its function is depending on the co-factors it interacts
with. This pattern may be similar to other C2H2 Zfps harbouring
multiple zinc fingers [43,44]. Taken together, we hypothesize that
Zfp322a function as a coordinator that fine tunes the association
and recruitments of various factors, including Oct4. It would be
interesting to further examine the association of Zfp322a with
other components of Oct4/Sox2 regulatory cluster and also Myc
cluster proteins to examine their interactions.
Considering the relatively low efficiency and considerable time
for the OKSM reprogramming process, many studies focused on
finding new factors or developing new methods that can accelerate
the kinetics of reprogramming process or defining the reprogram-
ming mechanism. Ourresults fromiPSC formationassaysidentified
Zfp322a asa novelreprogrammingenhancerthat canreplaceSox2,
thus expanding the current reprogramming code. Addition of
Zfp322a was shown to induce OKSM reprogramming more
efficiently and faster than OKSM alone, suggesting that Zfp322a,
as a partner of Oct4 and a key regulator of mES pluripotency, can
accelerate and enhance the efficiency of this process. To our
understanding, Zfp322a seems to have a more remarkable role in
increasing the portion of GFP
+ colonies than increasing the number
of AP
+ colonies. Since the expression of GFP indicates the
reactivation of ES cell marker Pou5f1, this implies that Zfp322a
could facilitate the transition of partially reprogrammed AP
+
colonies towards fully reprogrammed GFP
+ colonies.
There are several possible ways in which Zfp322a can enhance
reprogramming. Firstly, overexpression of Zfp322a has been
shown to activate Nanog expression. Although Nanog is not one
of the canonical quartets of transcription factors used for
reprogramming, it is essential for the transition from dedifferen-
tiated intermediates to ground state pluripotency [45]. Thus the
enhancement and acceleration of reprogramming brought by
Zfp322a could be partially facilitated by Nanog induction. This
may also be the same mechanism shared by Nr5a2 and Zfp296 in
their enhancement of reprogramming efficiency [12,40]. Secondly,
reprogramming process consists of down-regulation of lineage
specific markers, activation of ES cell genes and widespread
chromatin remodelling to re-establish the unique chromosomal
confirmation of ES cells. As mentioned previously, Zfp322a was
shown to repress the lineage specific markers and act as an
activator for mES pluripotency genes (Figure 1). ChIP-seq analysis
revealed that Zfp322a has many targets involved in chromosome
assembly and modifications. Recruitment of epigenetic modifiers,
such as histone acetyltransferases, and inhibition of DNA
methytransferases and histone deacetylases, can promote repro-
gramming by loosening the condensed chromatin and thus
enabling the exogenous reprogramming factors to access and
transcribe pluripotency genes and jumpstart the pluripotency
transcriptional network. Therefore, Zfp322a could possibly aid in
reprogramming by activating directly or establishing a permissive
chromatin state to allow the transcriptions of mES cell-specific
genes. Thirdly, Zfp322a may promote the reprogramming via
facilitating Oct4/Sox2 functions. Given our observation that
Zfp322a is an interacting partner of Oct4 that can replace Sox2 in
the OKSM reprogramming, it can be inferred that Zfp322a has
similar functions of Sox2. Fourthly, the suppression of MAPK/
ERK pathway is implicated in the predicted Zfp322a direct
Figure 5. Zfp322a can enhance OSKM reprogramming and replace Sox2. (A) Zfp322a enhanced reprogramming efficiency and accelerated
the onset of reprogramming process. OSKM serves as control experiment. (B) The iPSCs generated from OSKM plus Zfp322a presented alkaline
phosphatase activity. There were more AP stained colonies generated from OKSM+Zfp322a compare to OKSM. (C) The iPSCs expressed endogenous
Oct4, Nanog, Sox2, Rex1 and SSEA-1, indicating that they were ES-cell like. Immunostaining using anti-Oct4, anti-Nanog anti-Sox2, anti-Rex1 and anti-
SSEA-1 antibodies were performed with GFP
+ iPSCs generated from OKSM+Zfp322a. (D) GFP
+ iPSCs generated by OKSM+Zfp322a were able to
express ectoderm, mesoderm and endoderm lineage markers in the EB formation assay. iPSCs were stained with anti-Nestin, anti-Gata4 and anti-
alpha smooth muscle actin (SMA) antibodies and pictures were taken at 606magnification. DAPI (blue) served as nucleus marker. (E) Zfp322a was
able to replace Sox2, but not Oct4 or Klf4 in OSKM reprogramming process. Results from three independent experiments were presented. (F) iPSCs
generated from OKM plus Zfp322a were positive with AP staining and more AP positive colonies were observed in OKM+Zfp322a as compared to
OKSM. (G) iPSCs generated by OKM plus Zfp322a expressed pluripotency markers Oct4, Nanog, Sox2, Rex1 and SSEA-1. (H) iPSCs derived from
OKM+Zfp322a could differentiate into ectoderm, mesoderm and endoderm lineages, which were showed by anti-Nestin, anti-Gata4, anti-SMA
staining respectively.
doi:10.1371/journal.pgen.1004038.g005
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the elevated p-ERK level upon Zfp322a RNAi indicates that
Zfp322a could repress ERK pathway but not ERK expression.
ERK pathway has been shown to trigger mES cell differentiation
[46]. Inhibition of this pathway is important for maintaining the
ground pluripotent state of mES cells and can improve somatic cell
reprogramming efficiency as well [21,47]. Thus Zfp322a could
also possibly enhance the reprogramming efficiency via the
suppression of MAPK/ERK cascade. Therefore, Zfp322a can
maintain mES cell properties and promote reprogramming
process in many aspects, yet the underlying mechanisms warrant
further investigations.
Although human and mouse ES cells are differed in the signaling
networks and epigenetic landscapes, it has been revealed that they
share the same core regulators Oct4/Sox2/Nanog and similar
transcriptional regulatory network, and the well-known Yamanaka
factorsOKSM areable todrive reprogramming of both human and
mouse somatic cells [6,48,49,50]. Given that Zfp322a is a conserved
zinc finger protein in human and mouse [16], we propose that
Zfp322a is extremely possible to have similar functions regarding
the maintenance and acquaintance of pluripotency in human cells,
which is very worthy to be elucidated in future studies.
Materials and Methods
Cell culture
Murine ES cells (E14) were cultured in ES cell medium consisting
of Glasgow Minimum Essential Medium (GMEM; Invitrogen),
15% ES cell qualified fetal bovine serum (FBS; Invitrogen),
0.055 mM b-mercaptoethanol (Sigma), 100 mM sodium pyruvate
(Invitrogen), 0.1 mM MEM nonessential amino acid (NEAA,
Invitrogen) and 1,000 units/ml of LIF (Millipore).
Platinum-E (Plat-E) cells were maintained in Plat-E medium
consisting of Dulbecco’s Modified Eagle Medium (DMEM;
Invitrogen) containing 10% FBS, 1% penicillin and streptomycin.
For cells transfected with retroviruses, medium were supplemented
with 1 ug/ml puromycin (Sigma-Aldrich) and 10 ug/ml blastici-
din (Invitrogen).
SNL feeder cells were maintained in GMEM, 10% FBS and 1%
P/S. Medium was changed every 2 days and cells were passaged
every 2–3 days. Inactivated SNL feeder cells were prepared by
adding Mitomycin C solution (12 mg/ml, Sigma) to cell culture
medium and cells were left to incubate for 2.5 h in 37uC with 5%
CO2 incubator. The inactivated cells were then passaged and
seeded at 80% confluence for culturing iPS cells.
Pou5f1-GFP MEFs were cultured in mESC medium without
LIF. For iPSC formation, MEFs that have been infected with
retroviruses were maintained in mESC medium without LIF till 5
days post infection and then maintained in Knockout Serum
Replacement (KSR) medium. KSR medium contains DMEM,
15% KSR (Invitrogen), 2 mM L- Glutamine (PAA), 1 mM sodium
pyruvate, 1000 units/ml of LIF, 1% P/S, 0.055 mM b-mercap-
toethanol and 0.1 mM MEM NEAA. All the cells were cultured in
37uC with 5% CO2 incubator.
Plasmid construction
For RNAi design and construction of plasmids for shRNA
synthesis, 19 base-pair gene-specific regions were designed.
Oligonucleotides were cloned into pSuper.puro (Oligoengine).
All sequences were analysed by BLAST to ensure specificity. For
overexpression studies, full-length Zfp322a (NM_172586.3) was
amplified by PCR and inserted into BamH1 and Xho1 site of
pPyCAGIP.
For plasmids used in luciferase assays, Pou5f1 CR4 region and
CR1 region was amplified and cloned into the pGL3-Promoter
vector (Promega) upstream of the firefly luciferase gene to give the
Pou5f1 CR4-pSV40-Luc and Pou5f1 CR1-pSV40-Luc luciferase
reporter plasmids respectively; Nanog proximal promoter was
amplified and inserted into pGL3-Basic vector to generate the
pNanog PP-Luc plasmid.
For retrovirus packaging plasmids, full-length Zfp322a cDNA
was amplified by PCR and ligated into MunI and NotI restriction
sites of pMX plasmid (Addgene).
The primers being used are available in the Supplementary
Table S8.
Transfection, RNA extraction, reverse transcription and
quantitative real-time PCR
Transfection was conducted using Lipofectamine 2000 (Invitro-
gen) according to the manual provided. For shRNA, cells were
selected in 6-well culture plate for 3 d using puromycin. ES cells
transfected with overexpression vectors were selected using
puromycin for 1 week before transferring to 100 mm plate for
further selection for another 1 week. Single colonies were picked
up and passaged to 6-well dishes. The cells were then harvested for
either extraction of protein or RNA. RNA extraction, reverse
transcription and qPCR for examine of gene expressions were
conducted according to previous studies [51]. For ChIP experi-
ments, relative occupancy values were calculated by determining
the apparent IP efficiency (ratios of the amount of ChIP enriched
DNA over that of the input sample) and normalized to the level
observed at a control region. All the qPCR primers are available in
Supplementary Table S8.
Microarray analysis
E14 cells were transfected as described above, with plasmid
expressing shRNA targeted against either Zfp322a or control. Cells
were harvested after 4 days selection. Total RNA was extracted
and purified as described above. Then the RNA was diluted to
200 ug/ul and was analyzed using Affymetrix Mouse Genome
MG430 Plus 2.0 Array according the manufacture’s instruction.
Microarray data was processed to extract the representative
intensities from each probe set using RMA [52]. Fold change of
1.5 was used to identify differential expression between the two
sample groups (knockdown versus wild type), and only differen-
tially expressed genes were subjected for further analysis. Prior to
hierarchical clustering, log2 transformation was first performed
and the transformed data were subtracted from the mean of the
means of the two sample groups. To identify the enriched ‘‘Gene
Ontology’’ (GO) terms in the differentially expressed genes, the
GO TermFinder [53] was applied. For presentation of enriched
KEGG pathways in the differentially expressed genes, the
GATHER [54] was used. The p value cut-off of 0.05 was employed
for both significant enriched GO terms and KEGG pathways. For
overlapping genes between ChIP-seq predicted targets and Micro-
array altered gene targets, two sets of genes were analysed using
VLOOKUP functions in Microsoft Excel. The microarray data has
been deposited to NCBI Gene Expression Omnibus (GEO) with
accession number GSE45139.
ChIP-seq
Chromatin was prepared using E14 cells as previously described
[55]. Sonicated chromatin was incubated with Protein G magnetic
Dynabeads (Invitrogen) coated with 40 ml of anti-ZNF322
antibody (sc-102205, Santa Cruz) overnight. The beads were
then washed and Elution buffer (50 mM Tris-HCl pH 8.0,
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for 45 min at 68uC with agitating at 1400 rpm. The eluent was
decrosslinked by pronase. Lastly, DNA was precipitated and
dissolved in nuclease free water for real-time PCR.
For ChIP-seq, ChIP DNA library was prepared by utilizing the
ChIP-seq Sample Prep Kit (Illumina). Sequencing was then
performed using the Genome Analyzer IIx (Illumina) and reads
were mapped to the M. musculus genome assembly mm9.
ChIP-seq data analysis
ChIP-seq peak detection was performed using Partek software
with an average fragment size of 300 bps and 0.05 as the cutoff p-
value of Mann-Whitney U test for the separation of forward and
reverse reads in a peak. In fact, the Partek software combined
several methods of fragment size estimation [56], peak identifica-
tion [57] and peak filtering using the Mann-Whitney U test. We
further enriched the peaks by using the fold change of Zfp322a
peak heights to IgG peak heights (fold change 3 as cut-off), and a
minimal Zfp322a peak height at 9 reads as a further cut-off
criterion (Figure S6). The final list of the inferred peaks was
subjected to Zfp322a motif finding. MEME-ChIP in the MEME
suite (http://meme.nbcr.net/meme/cgi-bin/meme-chip.cgi) was
applied to the inferred peaks. Clustering of Zfp322a with other
transcription factors (TFs) was used to evaluate the similarity of the
TF targeting. The co-localization between the TFs was first
computed and the correlation coefficients between each pair of co-
localization vector were then determined. With the completion of
all pair-wise correlation, a correlation matrix was obtained. With
the matrix, a heatmap reflecting the hierarchical clustering of the
correlation coefficients was generated. The Zfp322a ChIP-seq
data has been deposited to NCBI Gene Expression Omnibus
(GEO) with accession number GSE45138.
Western blot
Western Blot was carried out as previously described [51].
Primary antibodies used were: anti-ZNF322 antibody (sc-102205,
Santa Cruz), anti-b-actin (sc-81178, Santa Cruz), anti-Oct4
(sc-8628, Santa Cruz), and anti-Nanog (sc-33760, Santa Cruz),
anti-Sox2 (sc-99000, Santa Cruz), anti-Rex1 (sc-377095. Santa
Cruz), anti-p-ERK (sc-7383, Santa Cruz), anti-t-ERK (137F5, Cell
Signaling).
Immunofluorescence staining
Cells cultured in 24-well dishes were fixed in 4% paraformal-
dehyde and permeabilized with 0.25% Triton X-100, followed by
blocking with 3% BSA in PBS. Then cells were probed with
primary antibodyin 3% BSA for 1 h at 4uC and secondary
antibodyin 3% BSA for 30 min at room temperature. A drop of
Vectashield mounting medium with 49, 6-diamidino-2-phenylin-
dole (DAPI; Vector Laboratories) was placed on the microscope
slide and the cover slip was sealed with nail polish in a way that the
ES cells were in contact with the mounting medium. Staining
signal was then observed through the Axio Observer A1 inverted
light microscope (Zeiss). Primary antibody used were: anti-Oct4
(sc-8628, Santa Cruz), and anti-Nanog (sc-33760, Santa Cruz),
anti-Sox2 (sc-99000, Santa Cruz), anti-Rex1 (sc-377095, Santa
Cruz), anti-SSEA-1 (mab34301, Millipore), anti-alpha smooth
muscle Actin (ab5694, Abcam), anti-Nestin (mab2736, R&D),
anti-Gata4 (sc-25310, Santa Cruz).
Flow cytometry
Cells were collected by centrifugation and resuspended in PBS
with 4% formaldehyde for 10 min at 37uC. After chilled on ice for
1 min, the cells were resuspended in 90% methanol. The cells
were then incubated on ice for 30 min for permeabilization. The
cells were rinsed with incubation buffer (0.5% BSA in PBS). The
cells were incubated with primary antibody overnight at 4uC. The
cells were rinsed twice and then incubated with secondary
antibody for 1 h at room temperature in darkness. The cells were
rinsed twice before analysed on the flow cytometer (BD
FACSCanto). The flow cytometry results were analysed with flow
software 2.5.0.
Dual-luciferase assays
Gene-specific shRNA (600 ng) was cotransfected with
Pou5f1CR4-Luc reporter (600 ng), Pou5f1 PP-Luc or Nanog pp-Luc
reporter (600 ng) and an internal control pRL-TK (30 ng,
Promega) encoding Renilla luciferase. Firefly and Renilla luciferase
activities were measured with the dual-luciferase reporter system
(Promega) 72 h post-transfection by Ultra 384 Microplate Reader
(Tecan). The data generated from gene-specific shRNA cells were
expressed as relative to non-targeting shRNA control transfection,
after normalization to Renilla luciferase readings. Transfections were
performed in duplicate and on three independent occasions.
Alkaline phosphatase (AP) staining
AP staining was performed using Alkaline Phosphatase Detec-
tion Kit (Millipore) according to manufacturer’s instructions and
results were obtained using the Axio Observer A1 inverted light
microscope (Zeiss).
Retrovirus packaging and infection
Plat-E cells were seeded onto a 10 cm tissue culture plate at 50–
70% confluency and transfected with specific retrovirus packaging
plasmids 4–6 h later. Transfection was performed as normal RNAi
assays but in this experiment, 24 mg of plasmid, 60 mlo f
Lipofectamine 2000, and 1.5 ml of Optimen (Invitrogen) were
used instead. Cells were incubated overnight in a 37uC, 5% CO2
incubator before changing to fresh medium. Virus-containing
medium was collected 48 h post transfection, filtered using a
0.22 mm cellulose acetate filter (TPP) and concentrated 1006
using Amicon Centrifugal Filter Units-100 kDa (Millipore) by
centrifugation at 3800 rpm for 45 min. The concentrated viruses
were stored in 280uC for infection use. Pou5f1-GFP MEFs were
seeded onto a gelatin-coated 24 well plate at 50–70% confluency
6 h before infection. 10 ul of each concentrated retrovirus,
supplemented with 8 mg/ml polybrene (Sigma), were added to
the MEF cells. MEFs were then passaged onto the inactivated
feeder layer 2 dpi and maintained in mESC medium without LIF
before replacing with KSR medium at 5 dpi. KSR medium was
replaced every day and appearance of GFP
+ colonies was
observed.
EB formation assay
iPSCs were treated with 0.05%Trypsin/EDTA and then
cultured in ES medium without LIF in Ultra Low Culture Dish
(Corning) for 5 days. Then the EB were transferred to gelatin-
coated 24-well plate and cultured for 14 days. Immunostaining
were performed with antibodies for specific lineage markers.
Images were captured under a confocal microscope (Olympus
FV1000) at 606magnification.
Supporting Information
Figure S1 Zfp322a intronic region is bound by multiple
transcription factors. (A) The position of putative binding sites
was shown. The black box represents the amplified product from
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PLOS Genetics | www.plosgenetics.org 13 February 2014 | Volume 10 | Issue 2 | e1004038the primer pairs along the intronic region. Open boxes represent
exons of Zfp322.( B) Oct4 binds to Zfp322a intronic region. ChIP
DNA with anti-Oct4 antibody was analyzed by qPCR. Fold
enrichment was obtained after comparing the values of ChIP
DNA to that of the input DNA and normalized against a control
region.
(EPS)
Figure S2 Zfp322a in mES cells. (A) Zfp322a is distributed in
nucleus and cytoplasm in ES cells. ES cells were stained with anti-
ZNF322 antibody (green). DAPI (blue) served as nucleus marker.
(B) anti-ZFP322A antibody is specific to Zfp322a protein. E14 cell
lysate was prepared for western blot assay.
(EPS)
Figure S3 (A) Validation of gene expression microarray analysis
of Zfp322a RNAi. Eleven down-regulated genes and 10 up-
regulated genes were selected from microarray analysis. ES cells
transfected with empty pSUPER.puro vector were used as a
control and gene expression levels were normalized against b-actin.
Relative expression level of each gene in qPCR was compared to
microarray analysis results. (B) ERK inhibitors could not rescue
the down-regulated pluripotency genes in Zfp322a depleted cells.
(C) ERK inhibitors could bring down the up-regulated endoderm
and ectoderm lineage markers in Zfp322a knocked-down cells.
Mesoderm markers were elevated with the addition of ERK
inhibitors.
(EPS)
Figure S4 Relative luciferase activities were down-regulated
upon Zfp322a RNAi, Pou5f1 RNAi and Zfp322a & Pou5f1 double
RNAi using pSV40-Luc-CR4 construct (A) and pSV40-Luc-Nanog
PP construct (B). Two sample t-tests were performed with SPSS
software for statistical analysis. * indicated p value,0.05.
(EPS)
Figure S5 Zfp322a is required for ES cell pluripotency in HM1
cells. (A) Knockdown of Zfp322a drove ES cells differentiation.
Pluripotency genes Pou5f1, Nanog, Sox2 and Rex1 were down-
regulated upon Zfp322a depletion. (B) Zfp322a binds to Pou5f1
distal enhancer CR4. (C) Zfp322a binds to Nanog proximal
promoter region. (D) Zfp322a RNAi repressed luciferase activities
via CR4 and Nanog proximal prompter in HM1 cells.
(EPS)
Figure S6 Validation of ChIP-seq data to determine fold change
threshold. Genomic loci harbouringpeaks with variousfoldchanges
were randomly selected from the ChIP-seq data and categorized
into three groups: peak height with 9, 11 or more (.11). These
selected loci were validated using qPCR. The resultant enrichment
fold were shown in the vertical axis of the graph.
(EPS)
Figure S7 Zfp322a can replace Sox2 in the reprogramming
process. (A) iPSCs generated from OKM plus Zfp322a expressed
weak GFP. (B) iPSCs generated from OKM+Zfp322a were AP
positive.
(EPS)
Figure S8 Zfp322a overexpressing ES cells maintain undiffer-
entiated state. (A) Zfp322a overexpressing cells maintained ES cell
morphology and were AP positive. (B) Zfp322a overexpressing
cells displayed elevated Nanog expression. ES cells transfected
with empty pPCAGIP vector were used as a control and gene
expression levels were normalized against beta-actin. (C) Zfp322a
activates Nanog expression via Nanog proximal promoter. Dual
luciferase assay were performed using pSV40-Luc-Nanog pp
construct in control (empty pPyCAGIP vectors transfected) and
Zfp322a overexpressing cells. Renilla luciferase vector was
transfected simultaneously and relative luciferase activities were
normalized against Renilla luciferase activity.
(EPS)
Figure S9 Zfp322a may synergize Oct4 in maintaining ES cells
pluripotency. Zfp322a share many targets with Oct4. Genes that
displayed altered expression levels in gene expression microarray
analysis upon Zfp322a RNAi were compared to genes altered upon
Oct4 RNAi in previous study.
(EPS)
Table S1 Gene onthology analysis of altered genes in gene
expression microarray analysis after Zfp322a RNAi (p,0.05).
(XLSX)
Table S2 Enriched KEGG pathways for up-regulated genes in
gene expression microarray analysis after Zfp322a RNAi (p,0.05).
(XLSX)
Table S3 One hundred binding sites with top-ranked peak
heights in Zfp322a ChIP-seq analysis.
(XLSX)
Table S4 Representative enriched gene ontology terms in ChIP-
seq targets.
(XLSX)
Table S5 Enriched KEGG pathways for up-regulated direct
targets predicted by gene expression microarray and Chip-seq
analysis (p,0.05).
(XLSX)
Table S6 Gene ontology results of overlapping genes in the gene
expression microarray analysis of Zfp322a and Oct4 RNAi.
(XLSX)
Table S7 List of Oct4-interacting proteins whose encoding
genes were altered upon Zfp322a RNAi.
(XLSX)
Table S8 Sequences of primers.
(XLSX)
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